syed muhammad
Dr. Sayed Muhammed Zeeshan is a regulatory affairs and business development expert with extensive experience in the pharmaceutical and biological sciences sectors. He currently serves as the Sr. Manager Regulatory & Business Development at the Dow Institute of Biological Biochemical & Pharmaceutical Sciences (DUHS) in Karachi, Pakistan, where he leads strategic planning and clinical trial project budgeting. His expertise includes CTD product registration, lot release applications for biologicals, and the comprehensive management of clinical trials and bioequivalence studies. He holds a strong track record of facilitating international regulatory inspections, managing pharmacovigilance, and spearheading business development strategies for both local and global markets. Backed by a Pharm-D from Hamdard University and an MBA from the Institute of Business Administration, he successfully blends clinical knowledge with sharp strategic planning. As a Certified Clinical Research Professional, he utilizes his robust regulatory and clinical trial experience to deliver practical, compliance-driven pharmaceutical instruction.
Experience
8+ Years
Regulatory and business development professional with deep expertise in clinical trials, biological product registration, and organizational strategic planning.
Industry Background
Pharmaceutical Regulatory Affairs & Business Development
Held roles at Kaizen Pharmaceuticals and Getz Pharma before taking on senior managerial roles at the Dow Institute of Biological Biochemical & Pharmaceutical Sciences (DUHS).
Academic Background
Pharm-D and MBA
Earned a Pharm-D from Hamdard University Karachi and an MBA from the Institute of Business Administration (IBA).
Areas of Contribution
PharmacovigilanceBasics of PharmacovigilanceRegulatory AffairsBioequivalence
